Canada Pension Plan Investment Board’s CRISPR Therapeutics CRSP Stock Holding History

Canada Pension Plan Investment Board’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.39M	Buy	43,900 +27,500	+168%	+$1.45M	﹤0.01%	892
2026 Q1	$780K	Buy	+16,400	New	+$865K	﹤0.01%	1078
2023 Q1	–	Sell	-2,200	Closed	-$89.4K	–	1093
2022 Q4	$89.4K	Buy	+2,200	New	+$117K	﹤0.01%	1035
2022 Q3	–	Sell	-5,500	Closed	-$334K	–	1226
2022 Q2	$334K	Buy	+5,500	New	+$323K	﹤0.01%	1011
2021 Q4	–	Sell	-80,978	Closed	-$9.06M	–	1473
2021 Q3	$9.06M	Hold	80,978	–	–	0.01%	591
2021 Q2	$13.1M	Buy	80,978 +55,355	+216%	+$6.73M	0.02%	494
2021 Q1	$3.12M	Buy	+25,623	New	+$3.87M	﹤0.01%	745

Other funds holding CRSP

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

GSK plc London $602M AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Canada Pension Plan Investment Board's CRSP Position: Q2 2026 in Review

Canada Pension Plan Investment Board increased its CRISPR Therapeutics (CRSP) stake by 168% in Q2 2026, buying an estimated $1.45M and bringing the position to 43,900 shares worth $2.39M. The position accounts for ﹤0.01% of the portfolio, ranked #892.

Canada Pension Plan Investment Board first reported a position in CRSP in Q1 2021 and has held it in 7 quarters since. The position peaked at $13.1M in Q2 2021. 521 funds tracked by Wall St. Rank hold CRSP as of Q2 2026.

Canada Pension Plan Investment Board held 43,900 shares of CRISPR Therapeutics worth $2.39M as of Q2 2026.
Canada Pension Plan Investment Board bought 27,500 CRISPR Therapeutics shares in Q2 2026, an estimated $1.45M.
CRISPR Therapeutics made up ﹤0.01% of Canada Pension Plan Investment Board's portfolio in Q2 2026, its #892 holding.
Canada Pension Plan Investment Board first reported a position in CRISPR Therapeutics in Q1 2021 and has held it in 7 quarters since.
Canada Pension Plan Investment Board's CRISPR Therapeutics position peaked at $13.1M in Q2 2021.
521 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q2 2026.

Based on Canada Pension Plan Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.